Loading organizations...
§ Private Profile · San Leandro, CA, USA
Developer of targeted cancer therapeutics for bladder cancer.
Rainier Therapeutics has raised $80.0M across 2 funding rounds.
Rainier Therapeutics has raised $80.0M in total across 2 funding rounds.
Rainier Therapeutics has raised $80.0M across 2 funding rounds. Most recently, it raised $50.0M Series B Extension in May 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 9, 2018 | $50M Series B Plus | — | HealthCap, INKEF Capital, LSP, Sectoral Asset Management, David Kabakoff, Tekla Capital Management, Ysios Capital | Announced |
| Mar 22, 2017 | $30M Series B | Cory Freedland, David Lacey | HealthCap, LSP, Tekla Capital Management | Announced |
Rainier Therapeutics has raised $80.0M in total across 2 funding rounds.
Rainier Therapeutics's investors include HealthCap, INKEF Capital, LSP, Sectoral Asset Management, David Kabakoff, Tekla Capital Management, Ysios Capital, Cory Freedland, David Lacey.